Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...

After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...

PLYMOUTH MEETING, Pa. - INOVIO (NASDAQ: INO), a biotechnology company with a market capitalization of approximately $69 million, has announced positive results from a Phase 1/2 clinical trial of ...

Researchers from TMC and NIBMG have uncovered key genomic factors contributing to hormone treatment resistance in breast cancer. The study identifies mutations in three genes, DNA repair deficiencies, ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Stock analysts at Zacks Small Cap raised their Q1 2025 earnings estimates for shares of Evaxion Biotech A/S in a research report issued to clients and investors on Thursday, February 6th. Zacks Small ...